CATX Perspective Q4 2025 EPS misses estimates by 403 percent shares dip 076 percent on soft quarterly results Why Northpointe Bancshares NPB might be the steady performer you need Breakout Watch 20260506 FENC Fennec Pharmaceuticals posts far wider than expected Q4 2025 loss even as shares tick higher How much upside is really left in Ascentage AAPG 077 20260505